Ventas (NYSE:VTR)‘s stock had its “neutral” rating restated by Zacks in a note issued to investors on Friday, StockRatingsNetwork.com reports. They currently have a $65.00 price target on the stock. Zacks‘ price target indicates a potential upside of 3.78% from the company’s current price.
Zacks‘ analyst wrote, “Ventas is scheduled to release its fourth quarter and year-end 2013 earnings before the opening bell on Feb 14. In December, the company made a hike in its quarterly cash dividend rate, which is encouraging. The company also closed a new $3 billion unsecured credit facility that helped extend maturities, improve pricing, and enhance term loans. Notably, aided by strategic investments made in 2013 and the prior year, Ventas’ third-quarter 2013 normalized FFO per share topped the Zacks Consensus Estimate. A rise in net operating income in its private pay seniors housing communities, triple-net lease portfolio, and medical office building segment drove that increase. Going forward, we expect the company to benefit from its diversified portfolio, growing healthcare spending and aging population. Strategic acquisitions and decent cash flows would add momentum to the company’s growth. Yet, its substantial exposure to long-term leased assets remains our concern and a large part of its revenues originate from a few tenants, thereby exposing it to concentration risks. “
Shares of Ventas (NYSE:VTR) traded down 0.51% during mid-day trading on Friday, hitting $62.63. The stock had a trading volume of 1,564,116 shares. Ventas has a one year low of $54.89 and a one year high of $84.11. The stock’s 50-day moving average is $59.99 and its 200-day moving average is $61.49. The company has a market cap of $18.418 billion and a price-to-earnings ratio of 43.09.
A number of other firms have also recently commented on VTR. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Ventas in a research note on Wednesday, January 15th. They now have a $58.00 price target on the stock, down previously from $64.00. Separately, analysts at RBC Capital upgraded shares of Ventas to an “outperform” rating in a research note on Tuesday, January 14th. Finally, analysts at UBS AG upgraded shares of Ventas from a “neutral” rating to a “buy” rating in a research note on Friday, January 10th. They now have a $63.00 price target on the stock. They noted that the move was a valuation call. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $66.63.
Ventas, Inc is a real estate investment trust (NYSE:VTR) with a geographically diverse portfolio of seniors housing and healthcare properties throughout the United States and Canada.
To view Zacks’ full report, visit www.zacks.com
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.